Showing posts with label chemical industry. Show all posts
Showing posts with label chemical industry. Show all posts

Tuesday, October 27, 2026

Chemie in der Krise: So will das Umweltbundesamt die Industrie bis 2050 umbauen

Die Mauer fiel und der Sozialismus breitete sich in ganz Deutschland aus!

Klimaneutral = Ein typisches deutsches Unwort oder blanker Unsinn!

Chemie in der Krise: So will das Umweltbundesamt die Industrie bis 2050 umbauen "Das Umweltbundesamt hat skizziert, wie Europas Chemieindustrie bis 2050 ohne Erdöl und klimaneutral [???] produzieren soll. Branchenverband und Gewerkschaft suchen den Dialog, warnen aber vor Werksschließungen und Konkurrenz aus China."

Spotlight 2026: Shaping the Chemical Transition Together (offiziell Umweltbundesamt) "... die Motivation der Teilnehmenden für eine möglichst klimaschonende An- und Abreise ..."

Tuesday, September 30, 2025

A global petrochemical shift to China from Europe

Bad news! This seems to follow the typical playbook of the Communist Party of China like solar panels, rare earth metals processing and other products before! Produce large quantities, export excess, use price dumping, exploit free trade.

When will Western countries finally wake up! President Trump is right to oppose this managed foreign trade by China! This is not free trade, but an attempt to dominate certain industries to the benefit of China. China got away with this for too long!

"The global petrochemicals landscape is undergoing a massive shift. According to a ranking of the top 100 chemicals firms by ICIS, China’s majority state-owned Sinopec has supplanted BASF at the top of the list, with three other Chinese firms in the top 10. That will come as no surprise to anyone with half an eye on this sector, since China has been supporting domestic firms to aggressively build new integrated petrochemicals plants to turn the country from a net importer of petrochemicals to an exporter."

Sinopec overtakes BASF as world's largest chemical company amid China's petrochemicals expansion | Chemistry World (no public access) "China’s rapid capacity expansion fuels global oversupply, leading plant closures in Europe and elsewhere"

Tuesday, July 15, 2025

Basic chemical industry is disappearing in Europe

Cause for concern! What will happen to the industrial base of Europe going forward? Is excessive environmentalism to blame, e.g. not in my backyard (NIMBY)?

"The last few weeks have been a tough time for basic chemicals manufacturing in the UK and Europe. 
Sabic has reversed its decision to refit and re-open its olefins cracker in Teesside, UK;
Prax group, operator of the UK’s Lindsey oil refinery on the banks of the Humber river, has entered administration; and
Dow Chemical has confirmed that it will close three European chemicals sites by the end of 2027 – an ethylene cracker in Böhlen, Germany, a chlor-alkali and vinyls plant in Schkopau, Germany, and a basic siloxanes plant in Barry, UK. ...

But basic chemicals are the foundation of huge swathes of manufacturing industry, and their closures will have significant long- and short-term impacts on regional production networks. As global trade is disrupted by political trade wars, relying on imports becomes a vulnerability. Efforts in China to boost domestic production (including significant state support) as well as the Middle East’s push to make more higher-value petrochemicals – rather than exporting crude oil – have exacerbated pressure on Europe’s aging plants. ..."

Cracking under pressure | Opinion | Chemistry World "Basic chemical plant closures highlight strain on European industry"

Sunday, April 07, 2024

Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost

Good news! Competition is good, more of it is better! Pardon, this is a bit of older news!

"A small Indian biotechnology company is producing a home-grown version of a cutting-edge cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy that was pioneered in the United States. CAR-T therapies are used mainly to treat blood cancers and have burgeoned in the past few years. The Indian CAR-T therapy costs one-tenth that of comparable commercial products available globally.
A single treatment of NexCAR19, manufactured by Mumbai-based ImmunoACT, costs between US$30,000 and $40,000. The first CAR-T therapy was approved in the United States in 2017, and commercial CAR-T therapies currently cost between $370,000 and $530,000, not including hospital fees and drugs to treat side effects. These treatments have also shown promise in treating autoimmune diseases and brain cancer.
India’s drug regulator approved NexCAR19 for therapeutic use in India in October. By December, ImmunoACT was administering the therapy to paying patients, and it is now treating some two-dozen people a month in hospitals across the country. ..."

Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.

Monday, November 20, 2023

German chemical giant Bayer shares sunk to lowest in over a decade on $1.5bn Roundup verdict and drug failure

Bad business news coming out of the banana republic Germany!

The chemical and pharmaceutical industry was once one of the leaders in the German  and global economy!

BioNTech is one of the few exceptions and bright spots!

"Bayer AG suffered its biggest drop ever, losing about €7.6 billion ($8.3 billion) in market value, after major legal and drug-development setbacks that raise pressure on its new leader to outline a turnaround plan. ..."

Bayer shares sunk to lowest in over a decade on $1.5bn Roundup verdict and drug failure | Fortune Europe

Sunday, March 08, 2020

The Indian chemical industry By McKinsey & Company

Good news! And McKinsey & Company is promoting it! Given the recent realization of significant uncertainties about the heavy dependence on supply chains from China especially in pharmaceutical intermediate products. India has a long tradition in manufacturing generics ...

The Indian chemical industry | McKinsey: The Indian chemical industry is positioned to capitalize on the near-term opportunities created by global uncertainties.